Targeting "bad" B cells in multiple sclerosis: Could laquinimod be part of the armamentarium?

Neurol Neuroimmunol Neuroinflamm. 2016 Sep 21;3(5):e283. doi: 10.1212/NXI.0000000000000283. eCollection 2016 Oct.

Authors

Thomas G Forsthuber¹, Olaf Stuve¹

Affiliation

¹ Department of Biology (T.G.F.), University of Texas at San Antonio; Department of Neurology and Neurotherapeutics (O.S.), University of Texas Southwestern Medical Center; and Neurology Section (O.S.), VA North Texas Health Care System, Medical Service, Dallas.

No abstract available

Publication types

Editorial